| 摘要 |
It is described a peptide consisting of a specific urogential carcinoma TLP epitope, wherein the TLP comprises the amino acid sequence GlyProProGluValGlnAsnAlaAsn. Also described are reagents to detect said urogenital TLP and pharmaceutical compositions.
|
